REGENERON PHARMACEUTICALS, INC. Other Non-current Liabilities 2009-2026 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current other non-current liabilities?
REGENERON PHARMACEUTICALS, INC. (REGN) annual other non-current liabilities for 2025 was $2.02B, a 28.47% increase from 2024. REGENERON PHARMACEUTICALS, INC. other non-current liabilities for the quarter ending March 31, 2026 was $2.13B.
What was REGENERON PHARMACEUTICALS, INC.'s other non-current liabilities in 2024?
REGENERON PHARMACEUTICALS, INC. annual other non-current liabilities for 2024 was $1.57B, a 83.98% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s other non-current liabilities in 2023?
REGENERON PHARMACEUTICALS, INC. annual other non-current liabilities for 2023 was $854.1M, a 33.87% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year other non-current liabilities CAGR?
REGENERON PHARMACEUTICALS, INC. other non-current liabilities grew at a compound annual growth rate (CAGR) of 24.06% from FY2020 to FY2025, going from $687.1M to $2.02B over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+24.1%
FY2020
$687.1M
→
FY2025
$2.02B
0910111213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.02B | +28.5% | 10-K |
| FY2024 | $1.57B | +84.0% | 10-K |
| FY2023 | $854.1M | +33.9% | 10-K |
| FY2022 | $638.0M | -6.2% | 10-K |
| FY2021 | $680.2M | -1.0% | 10-K |
| FY2020 | $687.1M | +116.3% | 10-K |
| FY2019 | $317.7M | -12.2% | 10-K |
| FY2018 | $361.7M | +138.0% | 10-K |
| FY2017 | $152.0M | +51.4% | 10-K |
| FY2016 | $100.4M | -13.1% | 10-K |
| FY2015 | $115.5M | +190.3% | 10-K |
| FY2014 | $39.8M | +251.3% | 10-K |
| FY2013 | $11.3M | +56.1% | 10-K |
| FY2012 | $7.3M | +12.7% | 10-K |
| FY2011 | $6.4M | -12.3% | 10-K |
| FY2010 | $7.3M | +85.7% | 10-K |
| FY2009 | $4.0M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →